The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Research Funding - Merck
The efficacy of immune checkpoint blockade for melanoma in-transit with or without nodal metastases: A multicenter cohort study.
 
Roger Olofsson Bagge
Consulting or Advisory Role - BD Bard; Bristol-Myers Squibb; Merck Sharp & Dohme; Novartis; Roche; Sanofi
Speakers' Bureau - Roche
Research Funding - BMS (Inst); Skyline Diagnostics (Inst)
 
Carl Jacob Holmberg
No Relationships to Disclose
 
Tina J. Hieken
Speakers' Bureau - Skyline Diagnostics
Research Funding - Genentech/Roche (Inst); Skyline Diagnostics (Inst)
 
Jonathan S. Zager
Stock and Other Ownership Interests - Johnson & Johnson/Janssen
Honoraria - Amgen; Castle Biosciences; Merck; Pfizer; Sanofi/Regeneron; Sun Pharma
Consulting or Advisory Role - Castle Biosciences; Delcath Systems; Philogen; Sanofi/Regeneron
Speakers' Bureau - Pfizer; Sun Pharma
Research Funding - Castle Biosciences (Inst); Delcath Systems (Inst); NeraCare GmbH (Inst); Philogen (Inst); Provectus (Inst)
Patents, Royalties, Other Intellectual Property - US Patent 10,583,246
Expert Testimony - Bubalo Law; McGowan, Hood, Felder & Phillips, LLC
Travel, Accommodations, Expenses - Amgen; Array BioPharma; Merck
 
Georgina V. Long
Honoraria - BMS; Pierre Fabre
Consulting or Advisory Role - Agenus; Amgen; Array BioPharma; Boehringer Ingelheim; Bristol-Myers Squibb; Evaxion Biotech; Hexal; Highlight Therapeutics; Merck Sharpe & Dohme; Novartis; OncoSec; Pierre Fabre; Provectus; QBiotics; Regeneron; Skyline Diagnostics
 
Alexander Christopher Jonathan Van Akkooi
Consulting or Advisory Role - 4SC (Inst); Amgen (Inst); Bristol-Myers Squibb (Inst); Merck/Pfizer (Inst); MSD Oncology (Inst); Novartis (Inst); Pierre Fabre (Inst); Sanofi (Inst); Sirius Medical (Inst)
Research Funding - Amgen (Inst); Bristol-Myers Squibb (Inst); Merck/Pfizer (Inst)
Travel, Accommodations, Expenses - Novartis
 
Giorgos C Karakousis
No Relationships to Disclose
 
Lalit Pallan
Speakers' Bureau - Bristol-Myers Squibb
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Lilly
 
John T. Vetto
Employment - Gilead Sciences (I)
Stock and Other Ownership Interests - Gilead Sciences (I); Roche/Genentech (I)
Speakers' Bureau - Castle Biosciences
Travel, Accommodations, Expenses - Castle Biosciences
 
David E. Gyorki
Honoraria - Amgen; BMSi; Novartis
Consulting or Advisory Role - Amgen; Bayer; QBiotics
Travel, Accommodations, Expenses - Amgen
 
Paolo Antonio Ascierto
Stock and Other Ownership Interests - PrimeVax
Consulting or Advisory Role - 4SC; Alkermes; Array BioPharma; AstraZeneca; Bio-AI Health; Boehringer Ingelheim; Bristol-Myers Squibb; Daiichi Sankyo; Eisai; Idera; Immunocore; Incyte; Italfarmaco; ITeos Therapeutics; Lunaphore Technologies; Medicenna; MedImmune; Merck Serono; Merck Sharp & Dohme; Nektar; Nouscom; Novartis; OncoSec; Pfizer; Pierre Fabre; Regeneron; Roche/Genentech; Sandoz; Sanofi; Seagen; Sun Pharma; Takis Biotech; Ultimovacs
Research Funding - Array BioPharma (Inst); Bristol-Myers Squibb (Inst); Roche/Genentech (Inst); Sanofi (Inst)
Travel, Accommodations, Expenses - Merck Sharp & Dohme
 
Reinhard Dummer
Honoraria - Alligator Bioscience; Amgen; Bristol-Myers Squibb; Catalym; MaxiVax ; MSD; Novartis; Pfizer; Pierre Fabre; Regeneron; Roche; Sanofi; Second Genome; Sun Pharma; T3 Pharmaceuticals; Takeda; touchIME
Consulting or Advisory Role - Alligator Bioscience; Amgen; Bristol-Myers Squibb; Catalym; MaxiVax ; MSD; Novartis; Pfizer; Pierre Fabre; Regeneron; Roche; Sanofi; Second Genome; Sun Pharma; T3 Pharmaceuticals; Takeda; touchIME
Research Funding - Amgen (Inst); Bristol-Myers Squibb (Inst); MSD (Inst); Novartis (Inst); Roche (Inst)
 
Jane Yuet Ching Hui
No Relationships to Disclose
 
Jacob Schachter
No Relationships to Disclose
 
Hildur Helgadottir
Consulting or Advisory Role - MSD; Novartis
Speakers' Bureau - Bristol-Myers Squibb
 
Hidde Kroon
No Relationships to Disclose
 
Luke Daniel Rothermel
No Relationships to Disclose
 
Matteo S. Carlino
Honoraria - Bristol-Myers Squibb; MSD; Novartis
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; Eisai; IDEAYA Biosciences; Merck Serono; MSD; Nektar; Novartis; OncoSec; Pierre Fabre; QBiotics; Regeneron; Roche; Sanofi
 
Kristy Kummerow Broman
No Relationships to Disclose
 
Lars Ny
Consulting or Advisory Role - Bristol-Myers Squibb; MSD; Novartis; Pierre Fabre; Sanofi; Zealth
Speakers' Bureau - Bristol-Myers Squibb/Celgene; LEO Pharma; MSD; Novartis; Pfizer
Research Funding - MSD (Inst); Syndax (Inst)